Skip to main content
. Author manuscript; available in PMC: 2019 Nov 13.
Published in final edited form as: Curr Osteoporos Rep. 2018 Aug;16(4):443–457. doi: 10.1007/s11914-018-0453-9

Table 1.

Oncomine (https://www.oncomine.org) gene analysis comparing the expression of stearoyl-CoA desaturase (SCD1) in patient samples collected from metastatic or primary sites across all cancers. Leukemia and multiple myeloma samples were compared to normal bone marrow. Data were ordered by “overexpression,” and the threshold was adjusted to P value < 1E4; fold change, 2; and gene rank, top 10%

Gene Fold change P value Dataset Analysis
SCD1 3.22 1.49E−8 Xu melanoma Metastasis vs. primary
4.042 1.03E−9 Grasso prostate Metastasis vs. primary
1.770 1.32E−6 Jones renal Metastasis vs. primary
1.450 3.85E−6 Bittner ovarian Metastasis vs. primary
3.667 4.40E−4 Bhattacherjee lung Metastasis vs. primary
2.399 0.084 Weigelt breast Metastasis vs. primary
1.259 2.90E−4 Tothill ovarian Metastasis vs. primary
2.051 0.052 Garber lung Metastasis vs. primary
1.711 0.047 Jain endocrine (head and neck) Metastasis vs. primary
1.406 0.004 Anglesio ovarian Metastasis vs. primary
1.600 9.884E−4 Linn sarcoma Metastasis vs. primary
3.517 0.003 Riker melanoma Metastasis vs. primary
2.040 0.040 LaTulippe prostate Metastasis vs. primary
1.294 0.030 Bittner colon Metastasis vs. primary
1.754 1.840E−4 Durig leukemia T cell ALL vs. normal
1.465 7.88E−19 Haferlach leukemia CML vs. normal
1.388 1.72E−17 Haferlach leukemia T cell ALL vs. normal
1.702 6.86E−7 Andersson leukemia AML vs. normal
1.465 1.20E−5 Andersson leukemia B cell ALL vs. normal
1.681 5.00E−4 Andersson leukemia T cell ALL vs. normal
2.605 0.037 Rosenwald multi-cancer CLL vs. normal
1.518 0.044 Zhan myeloma 3 Smoldering myeloma vs. normal